Xenetic Biosciences XBIO
NASDAQ XBIO
$1.72 -0.21 (-10.88%)
As of: Oct 23, 2026 · 3:59 PM EDT

Xenetic Biosciences (XBIO) Amortization of Deferred Charges (2015 - 2019)

Updated

Analysis

Xenetic Biosciences (XBIO) Amortization of Deferred Charges (2015 - 2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Xenetic Biosciences 4.02 Mn -21.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 6,450.00
Dec 31, 2016 25,381.00
Sep 30, 2016 315,096.00
Jun 30, 2016 64,157.00
Mar 31, 2016 139,846.00
Dec 31, 2015 57,796.00
Sep 30, 2015 50,731.00
API Access

Xenetic Biosciences Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=XBIO&period=max&api_key=YOUR_API_KEY